摘要
随着2022年我国新型冠状(新冠)病毒感染高峰的结束,心血管外科患者逐渐返院治疗,心血管外科手术量激增。但新冠病毒背景下心血管外科临床业务的开展面临诸多问题。因此,北京安贞医院组织心血管外科及相关领域专家撰写本专家经验,总结新冠病毒感染后需行心血管外科手术治疗患者的临床决策,并在现有循证医学证据和相关专家临床实践经验基础上提出相应建议。主要内容包括新冠病毒感染患者心血管外科手术治疗指征的特殊要求、手术时机选择、围手术期(术前、术中和术后)管理的特殊要求等,旨在为新冠病毒感染患者接受心血管外科手术的合理决策提供借鉴。
The end of the COVID-19 infection peak in 2022 prompts a backlog of cardiovascular surgical patients to gradually return to the hospital,resulting in a surge in cardiovascular surgeries.However,against the backdrop of the COVID-19 pandemic,the clinical practice of cardiovascular surgery faces many problems.Therefore,organized by Beijing Anzhen Hospital,experts in cardiovascular surgery and related fields have formulated hospital expert experience on perioperative treatment principles of cardiovascular surgery for patients infected with COVID-19.This article summarizes the clinical decision-making of patients requiring cardiovascular surgery after COVID-19 infection,and advises on the corresponding recommendations according to the existing evidence-based medical evidence as well as the actual clinical practice experience of relevant experts.The main content of the article includes special requirements for cardiovascular surgical treatment indications in patients with COVID-19 infection,selection of surgical timing,special requirements of preoperative,intraoperative and postoperative management,etc.,which aims to provide COVID-19-infected patients with guidance on rational decision-making when receiving cardiovascular surgery.
作者
李海洋
董然
贡鸣
黑飞龙
贾明
来永强
刘楠
刘永民
王晟
王坚刚
王强
许斌
尤斌
赵冬
朱俊明
侯晓彤
张宏家
孙立忠
Li Haiyang;Dong Ran;Gong Ming;Hei Feilong;Jia Ming;Lai Yongqiang;Liu Nan;Liu Yongmin;Wang Sheng;Wang Jiangang;Wang Qiang;Xu Bin;You Bin;Zhao Dong;Zhu Junming;Hou Xiaotong;Zhang Hongjia;Sun Lizhong(Department of Cardiac Surgery,Beijing Institute of Heart,Lung and Blood Vessel Diseases,Beijing Anzhen Hospital,Capital Medical University,Beijing 100029,China)
出处
《中华胸心血管外科杂志》
CSCD
北大核心
2023年第7期385-392,共8页
Chinese Journal of Thoracic and Cardiovascular Surgery
基金
国家自然科学基金面上项目(82070483)
北京市医院管理中心临床技术创新项目(XMLX202107)。